GlassScriptPhysician profile
Amy Peters
NPI 1508687559
$2,463.20
in general payments reported to CMS, 2019-2025
13 companies · $2,463 in 2025
The $2,463 reported for 2025 was more than what 97% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $2,463.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,371 · Travel and Lodging: $1,093.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,370.69 |
| Travel and Lodging | $1,092.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,665.34 | 2025 | Watchman Access System, Watchman, Watchman Flx |
| Edwards Lifesciences Corporation | $180.94 | 2025 | Sapien 3 Ultra Resilia |
| Cvrx, INC. | $123.81 | 2025 | Barostim Neo System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $100.74 | 2025 | Jardiance |
| Merck Sharp & Dohme LLC | $83.65 | 2025 | Verquvo |
| Tactile Systems Technology INC | $66.58 | 2025 | Nimbl, Flexitouch Plus |
| Scpharmaceuticals INC. | $62.78 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $42.33 | 2025 | Lifevest |
| Regeneron Healthcare Solutions, INC. | $36.73 | 2025 | Evkeeza |
| Actelion Pharmaceuticals US, INC. | $32.66 | 2025 | Uptravi, Opsumit |
| Bayer Healthcare Pharmaceuticals INC. | $30.80 | 2025 | |
| Impulse Dynamics (USA) INC. | $20.96 | 2025 | Optimizer |
| Bridgebio Pharma, INC. | $15.88 | 2025 | Attruby |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Peters listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.